U.S. federal trademark · Serial No. 88229766
Medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; and providing an online searchable database in the fields of oncology, bioinformatics, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.